Home/Filings/4/0001567619-22-021344
4//SEC Filing

TomEnterprise AB 4

Accession 0001567619-22-021344

CIK 0001401040other

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 3:19 PM ET

Size

10.1 KB

Accession

0001567619-22-021344

Insider Transaction Report

Form 4
Period: 2022-12-02
Transactions
  • Sale

    Common Shares

    2022-12-02$1.24/sh2,855,847$3,526,9710 total(indirect: See Footnote 1)
  • Purchase

    Common Shares

    2022-12-02$1.24/sh+2,855,847$3,526,9712,855,847 total(indirect: See Footnote 2)
Transactions
  • Purchase

    Common Shares

    2022-12-02$1.24/sh+2,855,847$3,526,9712,855,847 total(indirect: See Footnote 2)
  • Sale

    Common Shares

    2022-12-02$1.24/sh2,855,847$3,526,9710 total(indirect: See Footnote 1)
Transactions
  • Purchase

    Common Shares

    2022-12-02$1.24/sh+2,855,847$3,526,9712,855,847 total(indirect: See Footnote 2)
  • Sale

    Common Shares

    2022-12-02$1.24/sh2,855,847$3,526,9710 total(indirect: See Footnote 1)
Footnotes (2)
  • [F1]These shares were owned directly by TomEnterprise AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEnterprise AB. Thomas Von Koch had the sole power to vote and dispose of these shares.
  • [F2]These shares are owned directly by TomEqt Private AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEqt Private AB. Thomas Von Koch has the sole power to vote and dispose of these shares.

Documents

1 file

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1
  • filerCIK 0001887435

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 3:19 PM ET
Size
10.1 KB